Optimization of Exhaled Biomarker Collection and Analysis
NCT05322785 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2026-03-27
Summary
This is an exploratory study designed to optimize, standardize, and validate novel breath biomarkers; there are no objective endpoints. The goal of this study is to generate pilot data to be used to generate hypothesis-driven studies.
Conditions
- Respiratory Disease
- Healthy
Interventions
- OTHER
-
Breath collection
Exhaled breath will be passively collected from subjects during quiet oral breathing through a simple mouthpiece or mask
Sponsors & Collaborators
-
Indiana University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 4 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-02
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
Countries
- United States
Study Locations
More Related Trials
-
Breath Analysis Based Disease Biomarkers
NCT04341012 ·Status: COMPLETED
-
Breath Analysis in Healthy Controls
NCT02595632 ·Status: COMPLETED
-
Asthma Breath Biomarker Assessment
NCT03084016 ·Status: COMPLETED
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
NCT01776398 ·Status: RECRUITING
-
Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers
NCT02490358 ·Status: COMPLETED
-
Respiratory Infection Monitoring
NCT04362631 ·Status: COMPLETED
-
Small RNA Profiling in EBC in Athletes
NCT07324252 ·Status: COMPLETED
-
Biomarkers in Dyspnea
NCT03056547 ·Status: COMPLETED ·Phase: NA
-
Exhaled Breath Condensate (EBC) Assessment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
NCT00448500 ·Status: COMPLETED
-
Exhaled Breath Analysis in Human Subjects
NCT05456009 ·Status: RECRUITING
-
EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.
NCT03055923 ·Status: COMPLETED
-
Predictive Value of Inflammatory Biomarkers and FEV1 for COPD
NCT03532893 ·Status: COMPLETED
-
Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients
NCT03300739 ·Status: COMPLETED
-
Identification of Volatile Organic Compounds in Exhaled Air During Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02529891 ·Status: TERMINATED
-
Biomarker of Acute Exacerbation of COPD
NCT04963244 ·Status: COMPLETED
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Novel Biomarkers in Chronic Airway Diseases
NCT00849836 ·Status: UNKNOWN
-
Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath
NCT00442468 ·Status: COMPLETED
-
Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis
NCT03643263 ·Status: COMPLETED
-
Air Pollution and Health of COPD Patients
NCT05076630 ·Status: COMPLETED
-
Chronic Obstructive Pulmonary Disease (COPD) Biomarker Identification Study
NCT01780298 ·Status: COMPLETED
-
Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate
NCT04598620 ·Status: COMPLETED
-
Blood Collection From Individuals With Lung Disease for Genetic Studies
NCT00362739 ·Status: COMPLETED
-
Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease
NCT05214508 ·Status: COMPLETED ·Phase: NA
-
Sample Collection in Smoking Asthma
NCT01676467 ·Status: COMPLETED